| 英文别名： |
ERLOTINIB;ERLOTINIB HCL;ERLOTINIB HCL SALT;4-[(3-ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline;n-(3-ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine;Erlotinib Hydrochloirde;4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-;Tarceva;ERLOTININ;Erlotinib &its intermediates (Developing);Erlortinib;Erlotinib (OSI-774,CP-358,774, Ro 50-8231);Erlotinib Base;Erlotinib Free Base;N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;(±)-Cloprostenol sodium;Erlotinib,OS-774;its intermediates;nchembio866-comp3;NSC718781;OSI 744;OSI-744;R1415;R-1415;UNII-J4T82NDH7E;J4T82NDH7E;[6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE;CP358774;N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine;AK142763;DSSTox_RID_81628;DSSTox_CID_26454;DSSTox_GSID_46454;Er;[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl) |
